Evaluation of Performances and Safety of the Medical Device Blueback® Physio for Patients With Chronic Low Back Pain
NCT ID: NCT04592094
Last Updated: 2023-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2020-11-16
2022-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Biofeedback Training to Correct Abnormal Neuromechanical Pattern in Chronic Low Back Pain Patients
NCT02239289
Spinal Kinematics Variability
NCT03507296
Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain
NCT03266107
Oxygenation of Paravertebral Muscles During Exercise in Chronic Low Back Pain Patients
NCT03055182
Neurophysiological Assessment of Spinal Excitability in Chronic Low Back Pain
NCT05402904
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Blueback® Physio is a CE marked class I medical device. This medical device allows to measure and visualize in real time the activity of the transversus abdominal muscle, one of the deepest muscle of the abdominal wall. It is placed on the patient, during a rehabilitation session with a mhysiotherapist.
The objective is to optimize the three key phases followed by the healthcare professional: teaching his patient to feel the contraction of the muscle, learning to control this contraction, then learning to master this contraction when the patient is in double task (movements rehabilitation targeting other muscles, cognitive tasks or other tasks of everyday life that strain the spine).
In the ABC-TRACC study, the objective is to compare the time needed for patient to get a good motor control on his transversus abdominal muscle if he is using the Blueback® Physio during his sessons or not.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blueback® Physio
Classic protocole with the use of Blueback® Physio during physiotherapy sessions, , and using the Blueback® Physio in the active mode (patient and physiotherapists see the biofeedback in real time)during the tests required by the protocol of the study.
Blueback® Physio
Blueback® Physio is monitoring the activation level of the transversus abdominis muscle in real time during the exercises
Standard Care
Classic protocole without the use of Blueback® Physio during physiotherapy sessions, and using the Blueback® Physio in the blind mode during the tests required by the protocol of the study
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blueback® Physio
Blueback® Physio is monitoring the activation level of the transversus abdominis muscle in real time during the exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering from chronic low back pain (= low back pain installed for more than 2 months),
* Beneficiary of a social security,
* For which his consent has been obtained in writing with regard to his participation in the protocol.
Exclusion Criteria
* Having a contraindication to performing the muscular exercises provided for in the protocol,
* Having any other condition which, in the opinion of healthcare professionals, could affect its ability to complete the study or could present a significant risk,
* Simultaneously participating in another clinical research protocol or having recently participated in another research for which the exclusion period has not been completed.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Slb Pharma
OTHER
Blueback
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin MARGO, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Médical et Pédagogique de Beaulieu
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique FSEF Rennes BEAULIEU
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A00651-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.